FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Pharmacy Innovations Clindamycin/EDTA Calcium 4 Recall

Clindamycin/EDTA Calcium 4

Pharmacy Innovations · Erie, PA

Risk level
Class II
Reported by FDA
Feb 1, 2023
Recall ID
D-0199-2023
Check your lot numberHow we source this data

Summary

Pharmacy Innovations recalled Clindamycin/EDTA Calcium 4 starting Dec 22, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0199-2023 on Feb 1, 2023. Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Product description

Clindamycin/EDTA Calcium 4.1667MG/0.333MG/ML (30ML syringe) Irrigation, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

Lot numbers, UPCs & expiration codes

t20221109@41

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0199-2023
Classification
Class II
Status
Terminated
Recall initiated
Dec 22, 2022
FDA report date
Feb 1, 2023
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Pharmacy Innovations

Original FDA data

Every field from FDA enforcement report D-0199-2023, exactly as published.

Show all FDA fields
City
Erie
State
PA
Status
Terminated
Country
United States
Event ID
91332
Address
2936 W 17th St
Code information
t20221109@41
Postal code
16505-3929
Report date
Feb 1, 2023
Product type
Drugs
Recall number
D-0199-2023
Classification
Class II
Recalling firm
Pharmacy Innovations
Termination date
Jul 31, 2024
Reason for recall
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clindamycin/EDTA Calcium 4.1667MG/0.333MG/ML (30ML syringe) Irrigation, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Distribution pattern
Nationwide in the USA
Recall initiation date
Dec 22, 2022
Initial firm notification
Telephone
Center classification date
Jan 26, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0199-2023, published Feb 1, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls